This website is intended for Health Care Professionals in Croatia.
This website is intended for Health Care Professionals in Croatia.
Za Informacije o lijeku kliknite ovdje
Informacije o prijavljivanju nuspojava nalaze se na dnu stranice
Za Informacije o lijeku kliknite ovdje.
Informacije o prijavljivanju nuspojava nalaze se na bottom dnu stranice

FORXIGA (dapagliflozin) i zatajivanje srca
FORXIGA (dapagliflozin) has a well-established safety profile and is able to reduce the composite of risk of hospitalisation for heart failure (hHF) and cardiovascular (CV) death compared with placebo1-3
